268 related articles for article (PubMed ID: 33687876)
1. Water Mapping and Scoring Approaches to Predict the Role of Hydration Sites in the Binding Affinity of PAK1 Inhibitors.
Biswal J; Jayaprakash P; Rayala SK; Venkatraman G; Rangasamy R; Poopandi S; Jeyakanthan J
Comb Chem High Throughput Screen; 2022; 25(4):660-676. PubMed ID: 33687876
[TBL] [Abstract][Full Text] [Related]
2. Identification of Pak1 inhibitors using water thermodynamic analysis.
Biswal J; Jayaprakash P; Suresh Kumar R; Venkatraman G; Poopandi S; Rangasamy R; Jeyaraman J
J Biomol Struct Dyn; 2020 Jan; 38(1):13-31. PubMed ID: 30661460
[TBL] [Abstract][Full Text] [Related]
3. Potential target identification for breast cancer and screening of small molecule inhibitors: A bioinformatics approach.
Agarwal S; Kashaw SK
J Biomol Struct Dyn; 2021 Apr; 39(6):1975-1989. PubMed ID: 32186248
[TBL] [Abstract][Full Text] [Related]
4. WaterMap and Molecular Dynamic Simulation-Guided Discovery of Potential PAK1 Inhibitors Using Repurposing Approaches.
Biswal J; Jayaprakash P; Rayala SK; Venkatraman G; Rangaswamy R; Jeyaraman J
ACS Omega; 2021 Oct; 6(41):26829-26845. PubMed ID: 34693105
[TBL] [Abstract][Full Text] [Related]
5. WScore: A Flexible and Accurate Treatment of Explicit Water Molecules in Ligand-Receptor Docking.
Murphy RB; Repasky MP; Greenwood JR; Tubert-Brohman I; Jerome S; Annabhimoju R; Boyles NA; Schmitz CD; Abel R; Farid R; Friesner RA
J Med Chem; 2016 May; 59(9):4364-84. PubMed ID: 27054459
[TBL] [Abstract][Full Text] [Related]
6. Virtual Screening of Novel Glucosamine-6-Phosphate Synthase Inhibitors.
Lather A; Sharma S; Khatkar A
Comb Chem High Throughput Screen; 2018; 21(3):182-193. PubMed ID: 29600755
[TBL] [Abstract][Full Text] [Related]
7. Incorporating replacement free energy of binding-site waters in molecular docking.
Sun H; Zhao L; Peng S; Huang N
Proteins; 2014 Sep; 82(9):1765-76. PubMed ID: 24549784
[TBL] [Abstract][Full Text] [Related]
8. Molecular modelling approaches predicted 1,2,3-triazolyl ester of ketorolac (15K) to be a novel allosteric modulator of the oncogenic kinase PAK1.
Shahinozzaman M; Ahmed S; Emran R; Tawata S
Sci Rep; 2021 Sep; 11(1):17471. PubMed ID: 34471161
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
Iqbal S; Anantha Krishnan D; Gunasekaran K
J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
[TBL] [Abstract][Full Text] [Related]
10. Targeting protein tyrosine phosphatase to unravel possible inhibitors for Streptococcus pneumoniae using molecular docking, molecular dynamics simulations coupled with free energy calculations.
Zaman Z; Khan S; Nouroz F; Farooq U; Urooj A
Life Sci; 2021 Jan; 264():118621. PubMed ID: 33164832
[TBL] [Abstract][Full Text] [Related]
11. Addressing limitations with the MM-GB/SA scoring procedure using the WaterMap method and free energy perturbation calculations.
Guimarães CR; Mathiowetz AM
J Chem Inf Model; 2010 Apr; 50(4):547-59. PubMed ID: 20235592
[TBL] [Abstract][Full Text] [Related]
12. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
[TBL] [Abstract][Full Text] [Related]
13. Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies.
Mora Lagares L; Minovski N; Caballero Alfonso AY; Benfenati E; Wellens S; Culot M; Gosselet F; Novič M
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517082
[TBL] [Abstract][Full Text] [Related]
14. Identification of Phytochemicals Targeting c-Met Kinase Domain using Consensus Docking and Molecular Dynamics Simulation Studies.
Aliebrahimi S; Montasser Kouhsari S; Ostad SN; Arab SS; Karami L
Cell Biochem Biophys; 2018 Jun; 76(1-2):135-145. PubMed ID: 28852971
[TBL] [Abstract][Full Text] [Related]
15. Performance of MDockPP in CAPRI rounds 28-29 and 31-35 including the prediction of water-mediated interactions.
Xu X; Qiu L; Yan C; Ma Z; Grinter SZ; Zou X
Proteins; 2017 Mar; 85(3):424-434. PubMed ID: 27802576
[TBL] [Abstract][Full Text] [Related]
16. Probing the "fingers" domain binding pocket of Hepatitis C virus NS5B RdRp and D559G resistance mutation via molecular docking, molecular dynamics simulation and binding free energy calculations.
Manjula S; Sivanandam M; Kumaradhas P
J Biomol Struct Dyn; 2019 Jun; 37(9):2440-2456. PubMed ID: 30047829
[TBL] [Abstract][Full Text] [Related]
17. A computational approach to explore and identify potential herbal inhibitors for the p21-activated kinase 1 (PAK1).
Shahinozzaman M; Ishii T; Ahmed S; Halim MA; Tawata S
J Biomol Struct Dyn; 2020 Aug; 38(12):3514-3526. PubMed ID: 31448698
[TBL] [Abstract][Full Text] [Related]
18. Computational insight into the mechanisms of action and selectivity of Afraxis PAK inhibitors.
Han D; Wang H; Cui W; Zhang B; Chen BZ
Future Med Chem; 2020 Mar; 12(5):367-385. PubMed ID: 32064922
[No Abstract] [Full Text] [Related]
19. Extra precision docking, free energy calculation and molecular dynamics simulation studies of CDK2 inhibitors.
Tripathi SK; Muttineni R; Singh SK
J Theor Biol; 2013 Oct; 334():87-100. PubMed ID: 23727278
[TBL] [Abstract][Full Text] [Related]
20. 3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.
Chaudhari HK; Pahelkar A
Infect Disord Drug Targets; 2019; 19(2):145-166. PubMed ID: 30324898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]